Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 581
Clinical Trials 255
Immune Disorders Drugs 243
Cardiovascular Drugs 198
Drug Discovery 194
Pharmaceuticals 188
Infectious Diseases Drugs 174
Biopharmaceuticals 151
Central Nervous System Drugs 134
Endocrine and Metabolic Disorders Drugs 126
Musculoskeletal Disorders Drugs 109
Liver and Kidney Disorders Drugs 106
Leukemia Drugs 105
Hematological Drugs 96
Lymphoma Drugs 71
Dermatological Drugs 66
Brain Cancer Drugs 63
Diabetes Drugs 61
Skin Cancer Drugs 61
Gastrointestinal Drugs 52
Respiratory Drugs 51
Mental Disorders Drugs 47
Pharmaceutical Intermediates 46
Lung Cancer Drugs 46
Drug Delivery 42
Immunosuppressive Drugs 42
Liver Cancer Drugs 37
Pharmaceutical Manufacturing 37
Bladder Cancer Drugs 34
Infusions and Injectables 32
Analgesics 31
HIV/AIDS Drugs 27
Antibiotics 26
Colon Cancer Drugs 25
Drugs by Therapeutic Area 24
Kidney Cancer Drugs 24
Prostate Cancer Drugs 23
Cancer Vaccines 22
Schizophrenia Drugs 22
Sexual and Reproductive Health Drugs 21
Ovarian Cancer Drugs 20
Pancreatic Cancer Drugs 20
Breast Cancer Drugs 18
Cervical Cancer Drugs 17
Urological Disorders Drugs 17
Psoriasis Drugs 14
Over the Counter (OTC) Drugs 13
Vaccines 13
Thyroid Cancer Drugs 13
Biosimilars and Biosuperiors 12
Generic Drugs 10
Alzheimer's Disease Drugs 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Company Reports 7
Optical Disorders Drugs 7
Uterine Cancer Drugs 7
Addiction Disorders Drugs 4
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



280 reviews

3,036 Results (Page 4 of 152)
- Relevance
  Sort by

Hepatitis B Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

 Report
October 2023
190 Pages
Global

From

€4712EUR$4,900USD£4,042GBP

Anti-Rheumatics Market by Drug Class, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Type: Global Opportunity Analysis and Industry Forecast, 2019-2026

 Report
January 2020
202 Pages
Global

From

€5163EUR$5,370USD£4,430GBP

Organ Transplant Immunosuppressant Drugs Market - Growth, Trends, and Forecasts (2023-2028)

 Report
April 2023
114 Pages
Global

From

€4567EUR$4,750USD£3,918GBP

Global Atopic Dermatitis Drugs Market 2023-2027

 Report
April 2023
162 Pages
Global

From

€2404EUR$2,500USD£2,062GBP

Global Celiac Diseases Drugs Market 2023-2027

 Report
September 2023
155 Pages
Global

From

€2404EUR$2,500USD£2,062GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
92 Pages
Global

From

€3365EUR$3,500USD£2,887GBP

Hepatocellular Carcinoma Drugs Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4808EUR$5,000USD£4,124GBP

Bioavailability Enhancement Technologies and Services Market by Drug Class, BCS Classification, Bioavailability Enhancement Approach, Dosage Form and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
November 2022
270 Pages
Global

From

€5672EUR$5,899USD£4,866GBP

Global Sulphonamides Market

 Report
January 2024
200 Pages
Global

From

€3990EUR$4,150USD£3,423GBP

Global Skin Cancer Diagnostics & Therapeutics Market by Disease Type (Melanoma, Non-melanoma), Type (Diagnosis, Therapeutics) - Forecast 2023-2030

 Report
March 2024
190 Pages
Global

From

€3244EUR$3,374USD£2,783GBP

€3605EUR$3,749USD£3,092GBP

Psoriasis Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts ((2022 - 2027)

 Report
June 2022
120 Pages
Global

From

€4567EUR$4,750USD£3,918GBP

Advanced Renal Cell Carcinoma (RCC) - Market Insight, Epidemiology and Market Forecast -2032

 Report
January 2022
200 Pages
Global

From

€7212EUR$7,500USD£6,187GBP

Atopic Dermatitis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

 Report
February 2024
181 Pages
Global

From

€4712EUR$4,900USD£4,042GBP

Hepatitis C Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4808EUR$5,000USD£4,124GBP

Global HIV Drugs Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3990EUR$4,150USD£3,423GBP

Focal Segmental Glomerulosclerosis Drugs Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4808EUR$5,000USD£4,124GBP

Nephrology Drugs Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4808EUR$5,000USD£4,124GBP

Viral Hepatitis Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4808EUR$5,000USD£4,124GBP

Hepatitis B Virus (HBV) Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4808EUR$5,000USD£4,124GBP

Hepatitis Therapeutics Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4808EUR$5,000USD£4,124GBP

3,036 Results (Page 4 of 152)
- 1
- 2
- 3
- 4
- 5
- 6

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.